Adaptive Designs for Randomized Trials in Public Health

被引:104
作者
Brown, C. Hendricks [1 ]
Ten Have, Thomas R. [2 ]
Jo, Booil [3 ]
Dagne, Getachew [1 ]
Wyman, Peter A. [4 ]
Muthen, Bengt [5 ]
Gibbons, Robert D. [6 ]
机构
[1] Univ S Florida, Dept Epidemiol & Biostat, Prevent Sci & Methodol Grp, Tampa, FL 33612 USA
[2] Univ Penn, Sch Med, Dept Biostat, Philadelphia, PA 19104 USA
[3] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[4] Univ Rochester, Dept Psychiat, Rochester, NY 14642 USA
[5] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA 90095 USA
[6] Univ Illinois, Ctr Hlth Stat, Chicago, IL 60612 USA
关键词
multilevel trials; multistage trials; growth mixture models; encouragement designs; CACE modeling; principal stratification; EXTRACORPOREAL MEMBRANE-OXYGENATION; SAMPLE-SIZE REESTIMATION; PRINCIPAL STRATIFICATION APPROACH; CLUSTERED ENCOURAGEMENT DESIGNS; CLINICAL DRUG DEVELOPMENT; ADVANCE DIRECTIVE FORMS; SCHOOL CHOICE VOUCHERS; TO-TREAT ANALYSIS; PLAY-WINNER RULE; RUN-IN;
D O I
10.1146/annurev.publhealth.031308.100223
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this article, we present a discussion of two general ways in which the traditional randomized trial can be modified or adapted in response to the data being collected. We use the term adaptive design to refer to a trial in which characteristics of the study itself, such as the proportion assigned to active intervention versus control, change during the trial in response to data being collected. The term adaptive sequence of trials refers to a decision-making process that fundamentally informs the conceptualization and conduct of each new trial with the results of previous trials. Our discussion below investigates the utility of these two types of adaptations for public health evaluations. Examples are provided to illustrate how adaptation can be used in practice. From these case studies, we discuss whether such evaluations can or should be analyzed as if they were formal randomized trials, and we discuss practical as well as ethical issues arising in the conduct of these new-generation trials.
引用
收藏
页码:1 / 25
页数:25
相关论文
共 143 条
[1]  
Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
[2]  
[Anonymous], 1753, TREATISE SCURVY 3 PA
[3]  
[Anonymous], 2013, Clinical trials: a practical approach
[4]   A two stage conditional power adaptive design adjusting for treatment by covariate interaction [J].
Ayanlowo, A. O. ;
Redden, D. T. .
CONTEMPORARY CLINICAL TRIALS, 2008, 29 (03) :428-438
[5]  
Barnard J, 2003, J AM STAT ASSOC, V98, P299, DOI 10.1198/016214503000071
[6]  
BARTLETT RH, 1985, PEDIATRICS, V76, P479
[7]  
BARTLETT RH, 1976, T AM SOC ART INT ORG, V22, P80
[8]  
BEGG CB, 1989, STAT SCI, V4, P320
[9]   A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial [J].
Bekele, BN ;
Shen, Y .
BIOMETRICS, 2005, 61 (02) :344-354
[10]   UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years [J].
Bennett, CC ;
Johnson, A ;
Field, DJ ;
Elbourne, D .
LANCET, 2001, 357 (9262) :1094-1096